INS and prostate carcinoma: Moreover, given its association with late age of onset of low-grade prostate tumors, the polymorphism at +1127 INS-PstI may contribute to the unique features of prostate cancer that are not seen in other cancers, namely the high prevalence of latent and indolent cancers and the dramatic increase in incidence with age.